Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ciclopirox topical - Bausch Health Companies

Drug Profile

Ciclopirox topical - Bausch Health Companies

Alternative Names: 1% ciclopirox shampoo - Valeant Pharmaceuticals International; Loprox; Loprox cream; Loprox gel; Loprox Gel; Loprox shampoo; Loprox Shampoo; Loprox topical suspension

Latest Information Update: 17 Jul 2018

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Medicis Pharmaceutical Corporation
  • Developer Bausch Health Companies
  • Class Antifungals; Pyridones; Small molecules
  • Mechanism of Action Cell cycle inhibitors; DNA repair inhibitors; DNA synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Mycoses; Seborrhoeic dermatitis

Most Recent Events

  • 13 Jul 2018 Valeant Pharmaceuticals International is now called Bausch Health Companies
  • 11 Dec 2012 Valeant Pharmaceuticals acquires Medicis Pharmaceutical Corporation
  • 01 Mar 2012 US FDA approves ANDA application for generic version of ciclopriox gel 0.77% for seborrhoeic dermatitis of the scalp
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top